In the liability phase, the Federal Court (FC) found that Canadian Patent No. 1,161,380 (380 Patent) was valid and infringed by Apotex.
August 05, 2015
The Minister of Health refused to list a patent on the Patent Register in respect of a fixed-dose combination product because it did not contain a claim.
July 28, 2015
AstraZeneca Canada Inc. (AstraZeneca) appealed from the decision of Justice Rennie of the Federal Court (reported as AstraZeneca Canada Inc. v. Apotex Inc.
July 24, 2015
Horizon Pharma PLC (Horizon) is seeking approval to market the drug RAVICTI (glycerol phenylbutyrate) for the treatment of urea cycle disorders (UCDs).
July 14, 2015
Apotex Inc. and Apotex Pharmachem Inc. have been ordered by the Federal Court to pay to Adir and Servier Canada Inc.
July 10, 2015
O’Reilly J. granted a prohibition order sought by Novartis Pharmaceuticals Canada Inc. (Novartis) under section 6 of the PM(NOC) Regulations against Teva Canada Ltd.
July 08, 2015
On June 29, 2015, the Canadian Intellectual Property Office issued guidance to patent examiners on examining patent applications for medical diagnostic methods.
July 07, 2015
The Regulations Amending the Food and Drug Regulations more commonly known as the “Plain Language Labelling amendments” – came into force on June 13, 2015.
July 03, 2015
The Federal Court issued a Notice to the Parties and the Profession dated June 24, 2015 (the “Notice”).
July 02, 2015
The amendments to the Patented Medicines (Notice of Compliance) Regulations (PM(NOC) Regulations).
June 30, 2015
Try searching our global site instead